---
title: "Dogecoin Risk Appetite Expands as Bitcoin Climbs to $67367.66"
canonical_url: https://www.stockexpertai.com/journal/2026-03-31/dogecoin-risk-appetite-expands-as-bitcoin-climbs-to-6736766
last_updated: 2026-03-31T06:20:07.999Z
section: "Opinion Note"
author: "The StreetNews Editorial Board"
publisher: Stock Expert AI
tickers: BTC, ETH, DOGE, SLNO, MSFT
content_type: journal-article
---

# Dogecoin Risk Appetite Expands as Bitcoin Climbs to $67367.66

## The Take
- Monitor leverage shifts in crypto futures and stay informed about legal deadlines affecting your investments in companies like Soleno Therapeutics (SLNO).

_Crypto market sees shifting leverage strategies and legal woes for Soleno Therapeutics._

Here's our take on what matters most today.

The cryptocurrency market is exhibiting diverging trends, with Bitcoin reaching $67367.66 while Ethereum shows a shift toward coin-margined leverage. Dogecoin, meanwhile, sees broad-based leverage expansion, indicating increased risk appetite among traders. These changes in margin composition often signal shifts in trader conviction and hedging strategies, potentially impacting price volatility across different tokens.

In other news, Soleno Therapeutics (SLNO) faces legal challenges as Rosen Law Firm reminds investors of the May 5, 2026, lead plaintiff deadline in a securities class action. Investors who purchased SLNO common stock between March 26, 2025, and November 4, 2025, may be entitled to compensation. Separately, Cardano founder Charles Hoskinson has criticized Ripple for backing legislation that he believes could stifle competition and weaken DeFi protections.

* **Bitcoin:** Climbs to $67367.66 (+0.94%).
* **Ethereum:** Shift towards coin-margined leverage signals strategy change.
* **Dogecoin:** Broad leverage expansion suggests higher risk appetite.
* **Soleno Therapeutics (SLNO):** Faces securities class action; investors reminded of deadline. Shares closed at $30.44 (+1.30%).

## Related Tickers
- [BTC](https://www.stockexpertai.com/stock/btc)
- [ETH](https://www.stockexpertai.com/stock/eth)
- [DOGE](https://www.stockexpertai.com/stock/doge)
- [SLNO](https://www.stockexpertai.com/stock/slno)
- [MSFT](https://www.stockexpertai.com/stock/msft)

## Frequently Asked Questions

### Why is Dogecoin's risk appetite expanding?
The expansion of leverage in Dogecoin suggests traders are becoming more confident and willing to take on more risk. This often indicates a belief in further price increases, but also increases the potential for volatility. This can be a signal of market sentiment.

### What legal challenges does Soleno Therapeutics face?
Soleno Therapeutics (SLNO) is facing a securities class action lawsuit. Investors who purchased SLNO common stock between March 26, 2025, and November 4, 2025, may be eligible for compensation. The Rosen Law Firm has reminded investors of the May 5, 2026, lead plaintiff deadline.

---
_AI-generated under human editorial supervision. Educational research, not financial advice._